Ann: Quarterly Activity Report & Appendix 4C, page-48

Hi Varky,

You can start at looking the company website.

About Cymerus

The trademark Cymerus refers to the patented process of generating cell-based products from intermediate cells, known as mesenchymoangioblasts (MCAs), which in turn are derived from induced pluripotent stem cells (iPSCs). This technology was originally developed at the University of Wisconsin-Madison (UWM), a world-renowned leader in stem cell research.

The means of producing MCAs from pluripotent precursors, and the defining pattern of MCA cell surface markers, are the subjects of US patent 7,615,374, and a number of other patent applications in process around the world, licensed to or owned by Cynata.

At present, Cynata is focussed on the production of mesenchymal stem cell (MSC)-based products using the Cymerus technology.

https://www.cynata.com/about-cymerus

https://www.cynata.com/

Regards

Rossi70